Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
出版年份 2020 全文链接
标题
Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
作者
关键词
-
出版物
World Journal of Clinical Cases
Volume 8, Issue 24, Pages 6213-6228
出版商
Baishideng Publishing Group Inc.
发表日期
2020-12-19
DOI
10.12998/wjcc.v8.i24.6213
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metformin treatment decreases the expression of cancer stem cell marker CD44 and stemness related gene expression in primary oral cancer cells
- (2020) Shankargouda Patil ARCHIVES OF ORAL BIOLOGY
- Metformin as an Alternative Radiosensitizing Agent to 5FU During Neoadjuvant Treatment for Rectal Cancer
- (2020) Jennifer Marx Fernandes et al. DISEASES OF THE COLON & RECTUM
- A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice
- (2020) Lijuan Wang et al. GUT
- Role of gut microbiota-immunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes
- (2020) Ilenia Bartolini et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gut microbiota regulate tumor metastasis via circRNA/miRNA networks
- (2020) Zhuxian Zhu et al. Gut Microbes
- Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
- (2020) Jason R Brown et al. JCI Insight
- The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study
- (2020) Hanako Nakajima et al. Life-Basel
- Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development
- (2019) Jawara Allen et al. Genome Medicine
- Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity
- (2019) Thi Thinh Nguyen et al. Scientific Reports
- Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study
- (2019) Thomas Bryrup et al. DIABETOLOGIA
- Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors
- (2019) Ryo Okubo et al. BRAIN BEHAVIOR AND IMMUNITY
- Metformin and DPP-4 Inhibitor Differentially Modulate the Intestinal Microbiota and Plasma Metabolome of Metabolically Dysfunctional Mice
- (2019) Paul M. Ryan et al. Canadian Journal of Diabetes
- Colorectal adenoma resection brings moderate alteration to gut microbiota
- (2019) Si‐Yi Yu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells
- (2019) Gastón Amable et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer
- (2019) Wenhan Zhu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivo pharmacodynamic and pharmacokinetic effects of metformin mediated by the gut microbiota in rats
- (2019) Bin Wu et al. LIFE SCIENCES
- Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
- (2019) Shinichi Yachida et al. NATURE MEDICINE
- Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy
- (2019) Di-Wei Zheng et al. Nature Biomedical Engineering
- Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment
- (2019) TAKANORI HIRAYAMA et al. ANTICANCER RESEARCH
- Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
- (2019) Ji‐Hye Park et al. CANCER SCIENCE
- Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy
- (2019) Rosina Pryor et al. CELL
- Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
- (2019) Sunny H. Wong et al. Nature Reviews Gastroenterology & Hepatology
- Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
- (2019) Xiaohang Long et al. Nature Microbiology
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- Obesity, diabetes and the risk of colorectal adenoma and cancer
- (2019) Ghodratollah Soltani et al. BMC Endocrine Disorders
- Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes
- (2019) Joshua Demb et al. Clinical and Translational Gastroenterology
- Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice
- (2019) Lu Li et al. EBioMedicine
- The chemo-gut study: investigating the long-term effects of chemotherapy on gut microbiota, metabolic, immune, psychological and cognitive parameters in young adult Cancer survivors; study protocol
- (2019) Julie M. Deleemans et al. BMC CANCER
- Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
- (2019) Nathella Pavan Kumar et al. BMC INFECTIOUS DISEASES
- Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway
- (2019) Yi Xiao et al. Virulence
- Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin
- (2019) Saman Bahrambeigi et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
- (2018) Paige V. Bauer et al. Cell Metabolism
- The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC)
- (2018) Yaodu Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response
- (2018) Vrishketan Sethi et al. GASTROENTEROLOGY
- Gut microbiota modulate T cell trafficking into human colorectal cancer
- (2018) Eleonora Cremonesi et al. GUT
- Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings
- (2018) Paola Sena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression
- (2018) Wen-Shih Huang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
- (2018) Xiaolin Tong et al. mBio
- Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
- (2018) Felipe V. Pereira et al. Oncotarget
- Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30)
- (2018) Qing Yang et al. MEDICAL SCIENCE MONITOR
- Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
- (2018) Dorines Rosario et al. Frontiers in Physiology
- Type 2 diabetes in adolescents and young adults
- (2018) Nadia Lascar et al. Lancet Diabetes & Endocrinology
- Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK-1-eIF4G-eIF4E signaling
- (2018) Peng Shen et al. Molecular Oncology
- Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial–mesenchymal transition in human colon cancer cells
- (2018) Sanghee Kang et al. PLoS One
- Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice
- (2018) Shu-Qing Wang et al. CANCER BIOLOGY & THERAPY
- Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis
- (2018) Saul Soberanes et al. Cell Metabolism
- Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway
- (2018) Chu Zhang et al. Molecular Medicine Reports
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Does the antidiabetic drug metformin affect embryo development and the health of brown trout (Salmo trutta f. fario)?
- (2018) Stefanie Jacob et al. Environmental Sciences Europe
- Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through taurine generation in ovarian cancer cells
- (2018) Aniketh Bishnu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Metformin suppresses CRC growth by inducing apoptosis via ADORA1
- (2017) Bin Lan Frontiers in Bioscience-Landmark
- The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma
- (2017) Min Seok Han et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts
- (2017) Nur-Afidah Mohamed Suhaimi et al. MOLECULAR CANCER THERAPEUTICS
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells
- (2017) Sung-Hee Kim et al. Oncotarget
- Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
- (2017) Angela Mogavero et al. Scientific Reports
- Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer
- (2016) Vanessa C. Miranda et al. Clinical Colorectal Cancer
- Metformin Is Associated With Higher Relative Abundance of Mucin-DegradingAkkermansia muciniphilaand Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
- (2016) Jacobo de la Cuesta-Zuluaga et al. DIABETES CARE
- AMPK activation by metformin inhibits local innate immune responses in the isolated rat heart by suppression of TLR 4-related pathway
- (2016) Haleh Vaez et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Polyamine metabolism-based dual functional gene delivery system to synergistically inhibit the proliferation of cancer
- (2016) Peng-Fei Cui et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Protective effect of metformin in an aberrant crypt foci model induced by 1,2-dimethylhydrazine: Modulation of oxidative stress and inflammatory process
- (2016) Heloíza Paranzini Bordini et al. MOLECULAR CARCINOGENESIS
- Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis
- (2016) Zhihong Nie et al. PHARMACEUTICAL BIOLOGY
- The gut microbiota in conventional and serrated precursors of colorectal cancer
- (2016) Brandilyn A. Peters et al. Microbiome
- Colorectal cancer
- (2015) Herb Brody NATURE
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
- (2015) Xu Zhang et al. Scientific Reports
- Effect of Metformin on Metabolic Improvement and Gut Microbiota
- (2014) Heetae Lee et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Metformin aggravates immune-mediated liver injury in mice
- (2014) Vladislav Volarevic et al. ARCHIVES OF TOXICOLOGY
- Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies
- (2014) Wu-jie Bu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells
- (2014) Antoaneta Belcheva et al. CELL
- Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats
- (2014) Raylene A Reimer et al. JOURNAL OF ENDOCRINOLOGY
- Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2014) Zu-Bing Mei et al. PLoS One
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- A Gnotobiotic Mouse Model Demonstrates That Dietary Fiber Protects against Colorectal Tumorigenesis in a Microbiota- and Butyrate-Dependent Manner
- (2014) D. R. Donohoe et al. Cancer Discovery
- An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
- (2013) Na-Ri Shin et al. GUT
- Polyamines: Emerging players in bacteria–host interactions
- (2013) Maria Letizia Di Martino et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy
- (2013) Mehulkumar K. Kanadiya et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047
- (2010) Helena Cirenajwis et al. ANTI-CANCER DRUGS
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase
- (2010) Kunihiro Hosono et al. MOLECULAR CARCINOGENESIS
- Metformin suppresses intestinal polyp growth in ApcMin/+ mice
- (2008) Ayako Tomimoto et al. CANCER SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started